As per Future Market Insights’ latest analysis, the global antibody discovery market value is forecast to total USD 8.5 billion in 2024. Over the next decade, global antibody discovery demand will increase at around 9.9% CAGR, taking the total market valuation to USD 21.8 billion by 2034. This demonstrates the growing importance of antibodies in modern medicine.
Phage display remains the most widely used antibody discovery method owing to its versatility, robustness, applicability, and other advantages. The target segment is anticipated to thrive at 9.7% CAGR through 2034.
Multiple factors are predicted to stimulate the growth of the antibody discovery industry during the assessment period. These include the growing incidence of chronic diseases, escalating interest in antibody-based therapies, and advances in antibody discovery technologies.
As the burden of chronic diseases, such as cancer, diabetes, and autoimmune disorders, continues to mount, there is a growing demand for novel treatments like therapeutic antibodies. This is projected to boost the growth of the antibody discovery market during the assessment period.
Targeted therapies like antibody-based drugs are highly specific and can target disease-associated molecules. This is making them ideal for therapeutic interventions in a wide range of diseases. The growing adoption of these novel therapies will directly impact the growth of the target industry.
Surging demand for personalized medicine is another key factor propelling the global market forward. This is because antibodies play a key role in personalized medicine by targeting specific disease markers in patients.
Advances in antibody drug discovery technologies are making it easy for companies to develop new antibodies quickly and cost-efficiently. This will positively impact the growth of the antibody discovery industry during the assessment period.
Key Takeaways from the Report:
- The global market value is estimated to total USD 21.8 billion in 2034.
- By method, the phage display segment is set to register a CAGR of 7% through 2034.
- Based on antibody type, the human antibody category is poised to grow at 5% CAGR.
- Revenue in the United States is predicted to total USD 3.9 billion by 2034.
- China will record a CAGR of 7% between 2024 and 2034.
- Demand in South Korea is forecast to surge at a robust0% CAGR through 2034.
“As the burden of chronic and rare diseases continues to escalate, pharmaceutical giants are looking to develop novel antibody-based therapies. This, in turn, is set to create growth prospects for the antibody discovery industry through 2034.”- says a lead Future Market Insights (FMI) analyst.
Heightened Demand for Market Data: Our Full Report Provides Extensive Trend Analysis!
Who is Winning?
Leading players in the antibody discovery market include Danaher Corporation, Charles River Laboratories, Eurofins Scientific, Evotec, Twist Bioscience, Biocytogen, Sartorius AG, Fairjourney Biologics S.A, Genscript Technology Corporation, and Creative Biolabs.
Top companies are focusing on using advanced methods like hybridoma technology to create vast libraries of antibodies. Subsequently, they employ next-generation sequencing to analyze these libraries and identify promising candidates. Players are also adopting strategies like partnerships, collaborations, acquisitions, partnerships, and agreements to stay ahead of the curve.
Recent Developments:
- In April 2023, Bio-Rad Laboratories, Inc. introduced a new antibody discovery service specifically designed to develop best-in-class biologic candidates.
- In February 2024, SCIEX introduced Echo MS+system to address key challenges in high throughput screening applications for drug discovery.
Global Market Segmentation:
By Method:
- Phage Display
- Hybridoma
- Others
By Antibody Type:
- Humanized Antibody
- Human Antibody
- Chimeric Antibody
- Murine Antibody
By End-user:
- Pharmaceutical and Biotechnology Industry
- Research Laboratory
- Academic Laboratory
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube